Clinical Trial Update: Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating entinostat with clofarabine in newly diagnosed, relapsed, or refractory poor-risk acute lymphoblastic leukemia and bilineage/b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Bilineage Biphenotypic Leukemia
• Leukemias of Ambiguous Lineage
• Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia
• Untreated Adult Acute Lymphoblastic Leukemia

Drugs mentioned

• Clofarabine (clofarabine)
• Entinostat (entinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Acute Leukemias of Ambiguous Lineage, Philadelphia Chromosome Negative Adult Precursor Acute Lymphoblastic Leukemia | Phase 1 | Status: COMPLETED